Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Andersson

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1992
The drug lag issue: the debate seen from an international perspectiveF Andersson
Pharmacoeconomics|September 5, 1993
Methodological aspects of international drug price comparisonsF Andersson
Health Policy (Amsterdam, Netherlands)|April 8, 1992
Norway's pivotal role in regulatory health economics and pharmaceutical cost containment--what can other countries learn?F Andersson
Health Affairs (Project Hope)|January 1, 1993
Discourse on GAO drug price comparisonsF Andersson
International Journal of Technology Assessment in Health Care|January 1, 1995
Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?F Andersson
Health Policy (Amsterdam, Netherlands)|February 7, 1994
The distribution of pharmaceuticals in Europe--current and future trends in wholesalingF Andersson
Pharmacoeconomics|October 5, 1992
The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidenceF Andersson, E Hatziandreu
EDS Magazine : Official Journal of the E.E.C. Dental Students Committee|September 1, 1991
Student impressions of problem-based learningF Andersson, V Wallin
Lakartidningen|August 28, 1996
[The cost of angina. Reduction of productivity is as expensive as medical treatment]F Andersson, B Kartman
Lakartidningen|September 20, 1995
[Angina pectoris is as expensive as myocardial infarction. An unexpected result of a study]F Andersson, B Kartman
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1992
The drug lag issue: the debate seen from an international perspectiveF Andersson
Pharmacoeconomics|September 5, 1993
Methodological aspects of international drug price comparisonsF Andersson
Health Policy (Amsterdam, Netherlands)|April 8, 1992
Norway's pivotal role in regulatory health economics and pharmaceutical cost containment--what can other countries learn?F Andersson
Health Affairs (Project Hope)|January 1, 1993
Discourse on GAO drug price comparisonsF Andersson
International Journal of Technology Assessment in Health Care|January 1, 1995
Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?F Andersson
Health Policy (Amsterdam, Netherlands)|February 7, 1994
The distribution of pharmaceuticals in Europe--current and future trends in wholesalingF Andersson
Pharmacoeconomics|October 5, 1992
The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidenceF Andersson, E Hatziandreu
EDS Magazine : Official Journal of the E.E.C. Dental Students Committee|September 1, 1991
Student impressions of problem-based learningF Andersson, V Wallin
Lakartidningen|August 28, 1996
[The cost of angina. Reduction of productivity is as expensive as medical treatment]F Andersson, B Kartman
Lakartidningen|September 20, 1995
[Angina pectoris is as expensive as myocardial infarction. An unexpected result of a study]F Andersson, B Kartman
Pageof 16